MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1302-1303
Number of pages2
JournalRheumatology
Volume58
Issue number7
DOIs
Publication statusPublished - 2019

Cite this